{"id":"https://openalex.org/W2302074987","doi":"https://doi.org/10.1089/aid.2014.5144.abstract","title":"Topical Application of Broadly Neutralizing Monoclonal Antibodies Reduces HIV Infection of Mucosal Tissue","display_name":"Topical Application of Broadly Neutralizing Monoclonal Antibodies Reduces HIV Infection of Mucosal Tissue","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2302074987","doi":"https://doi.org/10.1089/aid.2014.5144.abstract","mag":"2302074987"},"language":"en","primary_location":{"id":"doi:10.1089/aid.2014.5144.abstract","doi":"https://doi.org/10.1089/aid.2014.5144.abstract","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2014.5144.abstract","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082509372","display_name":"Yanille Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanille Scott","raw_affiliation_strings":["University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025746769","display_name":"Kevin J. Whaley","orcid":"https://orcid.org/0000-0003-3856-6803","observed_orcids":["https://orcid.org/0000-0003-3856-6803"]},"institutions":[{"id":"https://openalex.org/I4210104471","display_name":"Mapp Biopharmaceutical (United States)","ror":"https://ror.org/01e47qp55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104471"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Whaley","raw_affiliation_strings":["Mapp Biopharmaceutical, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mapp Biopharmaceutical, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210104471"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085639427","display_name":"Charlene S. Dezzutti","orcid":"https://orcid.org/0000-0001-5902-5841","observed_orcids":["https://orcid.org/0000-0001-5902-5841"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210097282","display_name":"Magee-Womens Research Institute","ror":"https://ror.org/00rnw4e09","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210097282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charlene S. Dezzutti","raw_affiliation_strings":["Magee-Womens Research Institute, Pittsburgh, PA, United States","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Magee-Womens Research Institute, Pittsburgh, PA, United States","institution_ids":["https://openalex.org/I4210097282"]},{"raw_affiliation_string":"University of Pittsburgh School of Medicine, Pittsburgh, PA, United States","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"S1","first_page":"A78","last_page":"A78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/broadly-neutralizing-monoclonal-antibodies","display_name":"broadly neutralizing monoclonal antibodies","score":0.9480000138282776},{"id":"https://openalex.org/keywords/topical-application","display_name":"topical application","score":0.7319999933242798},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7350000143051147},{"id":"https://openalex.org/keywords/mucosal-tissues","display_name":"mucosal tissues","score":0.7990000247955322},{"id":"https://openalex.org/keywords/mucosal-immunity","display_name":"mucosal immunity","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7117677330970764},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6279538869857788},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5001819133758545},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4561048150062561},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3567488491535187},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28821682929992676}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1089/aid.2014.5144.abstract","doi":"https://doi.org/10.1089/aid.2014.5144.abstract","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2014.5144.abstract","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2238507651","https://openalex.org/W4210889017","https://openalex.org/W3045115723","https://openalex.org/W2176236970","https://openalex.org/W2250408263","https://openalex.org/W2295208626","https://openalex.org/W2761796548","https://openalex.org/W2536213055","https://openalex.org/W2756336116","https://openalex.org/W2301672843"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-08-15T07:11:24.734988","created_date":"2016-06-24T00:00:00"}